Bulava, Alan
Mokráček, Aleš
Němec, Petr
Wichterle, Dan
Osmančík, Pavel
Budera, Petr
Kačer, Petr
Vetešková, Linda
Skála, Tomáš
Šantavý, Petr
Chovančík, Jan
Branny, Piotr
Rizov, Vitalii
Kolesár, Miroslav
Šafaříková, Iva
Rybář, Marian
,
Funding for this research was provided by:
Ministry of Health of the Czech Republic (NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046, NV19-02-00046)
Article History
Received: 5 February 2024
Accepted: 15 June 2024
First Online: 27 June 2024
Declarations
:
: The trial protocol was approved by the institutional ethics committee of České Budějovice Hospital (ref. number 103/18, approved on 1st June 2018). Written informed consent was obtained from all patients before enrolment. The trial followed the Helsinki Declaration of 1964, its later amendments, and the Good Clinical Practice Guidelines.
: The authors declare no competing interests.